CTLA4 and neoplasm: However, one hypothesis suggests that CAR-T cell therapy for most tumor cells with unexpressed targeted antigen is unlikely to be successful unless combination strategies that enhance bystander effects are applied, and neither anti-PD-1/CTLA-4 antibodies stir bystander effects 171.